Cosmetic Hirudin Powder Leech Extract Hirudin

Cosmetic Hirudin Powder Leech Extract Hirudin

Hirudin is a highly specific, potent, and direct inhibitor of the serine protease thrombin, which occupies the central role in the coagulation cascade. Unlike indirect anticoagulants such as heparin, which require antithrombin III as a cofactor, hirudin exerts its effect by binding irreversibly and with high affinity to both the active catalytic site and the substrate recognition site (exosite I) of thrombin. This dual-binding mechanism creates a stable, stoichiometric 1:1 complex that completely inactivates thrombin's multifaceted functions. Crucially, hirudin inhibits not only free fluid-phase thrombin but also clot-bound thrombin—a form protected from inactivation by heparin-antithrombin complexes.

The clinical development and application of hirudin have primarily focused on its recombinant forms, given the limitations of natural extraction. Its major therapeutic role is in the prophylaxis and treatment of thrombotic disorders, particularly in patients who have developed or are at high risk for heparin-induced thrombocytopenia (HIT). In HIT, hirudin serves as a critical alternative anticoagulant to manage both the thrombocytopenic state and the associated high risk of arterial and venous thrombosis.

Beyond HIT, hirudin and its analogs have been extensively studied in acute coronary syndromes. They have demonstrated efficacy in preventing ischemic complications in patients undergoing percutaneous coronary intervention (PCI) and in the management of unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI). Another significant application is in the prevention of deep vein thrombosis (DVT) following major orthopedic surgeries.